D-0470-2017 Class III Terminated
FDA drug recall D-0470-2017 was initiated by Aurobindo Pharma USA Inc on Dec 16, 2016 and is designated Class III. Reason for recall: Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance. The recall status is terminated (terminated Jul 29, 2020). Affected quantity: 29800 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 15, 2017
- Initiation Date
- Dec 16, 2016
- Termination Date
- Jul 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29800 vials
Product description
Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00
Reason for recall
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Distribution pattern
Nationwide in US
Code information
Lot #: CPO160028, Exp. June 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0470-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026